Deadline: 5pm, Fri 20th Feb 2015
UCL Enterprise asks all UCL students and staff to help in honouring UCL’s enterprise activities by putting forth nominations for the 2015 Awards for Enterprise.
A new UCL spin-out company – Autolus – is being launch today to develop and commercialise a new generation of engineered T-cell therapies for haematological and solid tumours, with the backing of £30m in investment from healthcare investment company Syncona. More...
21 January 2015: Six new approaches to fighting neurodegeneration to be funded in SBC's OI challenge
Stevenage Bioscience Catalyst (SBC), the UK’s first open innovation bioscience campus, is delighted to announce that UCL was one of the six exciting academic research projects to have been selected for support under its open innovation challenge in neurodegenerative disease. More...
8 January 2015: Citrus Saturday raises £2500 for expansion in Swaziland
Citrus Saturday, UCL Advances’ initiative to encourage young people to consider entrepreneurship as a career option, has raised over £2500 through Indiegogo, the crowd-funding platform, to expand its reach in Swaziland. More...
22 December 2014: KTP funding success: The Bartlett School of Construction and Project Management collaborates with AECOM on market forecasting
The Bartlett School of Construction and Project Management has secured a three-year Knowledge Transfer Partnership with AECOM Professional Services LLP to develop a suite of innovative market forecasting tools. More...
17 December 2014: First patient dosed in trial of novel T-cell therapy for leukaemia Milestone for Cell Therapy Catapult, UCL Business & Imperial Innovations partnership
The first acute myeloid leukaemia patient has been dosed in a Phase I/ll cell therapy trial1 being undertaken by Catapult Therapy TCR Ltd, a partnership established in July 2014 to accelerate development of a novel T cell receptor (TCR) therapy. The trial is expected to involve five centres in the UK, and is to assess the safety and efficacy of the therapy, which targets diseases associated with overexpression of the WT1 antigen. Catapult Therapy TCR Ltd is an innovative partnership between the Cell Therapy Catapult, which is focused on the development of the UK cell therapy industry to increase the nation’s health and wealth, UCL Business (UCLB) and Imperial Innovations. More...
10 December 2014: UCL startup wins ‘Smart Cities’ pitch in Singapore
9 December 2014: UCL launches new crowdfunding platform
4 December 2014: UCL partners with culture, research and media organisations to launch the Knowledge Quarter
19 November 2014: Endomagnetics Raises Further Investment to Support US Clinical Trial, Sales Support and New Product Development
19 November 2014: Tech City UK and UCL launch the Digital Business Academy
14 November 2014: Tianjin and Shanghai join Cities Changing Diabetes on World Diabetes Day
11 November 2014: Crumbs! Student crumble business wins Selfridges slot
10 November 2014: Citrus Saturday launches Indiegogo campaign to expand Swaziland presence
3 November 2014: Houston joins Cities Changing Diabetes initiative
3 November 2014: Chirp secures funding to develop vertical applications
30 October 2014: Seven new ventures selected to join the first Health Social Innovators Programme in London
16 October 2014: Digital Business Academy opens for pre-registrations
10 October 2014: Director of UCL Advances shortlisted as finalist for Great British Entrepreneurship Awards
8 October 2014: Touch-free medical image navigation
8 October 2014: GCEC Conference ends on high with award win for UCL Advances